2-(2-butyl-4-methyl-1-((2'-(1-methyl- 1H-tetrazol-5-yl)-[1,1'-biphenyl]-4- yl)methyl)-6-oxo-1,6- dihydropyrimidin-5-yl)-N,Ndimethylethanethioamide 2-(2-butyl-4-methyl-1-((2'-(2-methyl- 2H-tetrazol-5-yl)-[1,1'-biphenyl]-4- yl)methyl)-6-oxo-1,6- dihydropyri

2-(2-butyl-4-methyl-1-((2'-(1-methyl-
1H-tetrazol-5-yl)-[1,1'-biphenyl]-4-
yl)methyl)-6-oxo-1,6-
dihydropyrimidin-5-yl)-N,Ndimethylethanethioamide
2-(2-butyl-4-methyl-1-((2'-(2-methyl-
2H-tetrazol-5-yl)-[1,1'-biphenyl]-4-
yl)methyl)-6-oxo-1,6-
dihydropyri Struktur
CAS-Nr.
Englisch Name:
2-(2-butyl-4-methyl-1-((2'-(1-methyl- 1H-tetrazol-5-yl)-[1,1'-biphenyl]-4- yl)methyl)-6-oxo-1,6- dihydropyrimidin-5-yl)-N,Ndimethylethanethioamide 2-(2-butyl-4-methyl-1-((2'-(2-methyl- 2H-tetrazol-5-yl)-[1,1'-biphenyl]-4- yl)methyl)-6-oxo-1,6- dihydropyri
Synonyma:
Fimasartan Impurity I;2-(2-butyl-4-methyl-1-((2'-(1-methyl-1H-tetrazol-5-yl)-[1,1'- biphenyl]-4-yl)methyl)-6-oxo-1,6-dihydropyrimidin-5-yl)-N,N- dimethylethanethioamide compound 2-(2-butyl-4-methyl-1 -((2'-(2-methyl-2H-t;2-(2-butyl-4-methyl-1-((2'-(1-methyl-1H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)methyl)-6-oxo-1,6-dihydropyrimidin-5-yl)-N,N-dimethylethanethioamide compound with 2-(2-butyl-4-methyl-1-((2'-(2-methyl-2H-tetrazol-5-yl)-[1,1'-biphenyl]-4-y;2-(2-butyl-4-methyl-1-((2'-(1-methyl-1H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)methyl)-6-oxo-1,6-dihydropyrimidin-5-yl)-N,N-dimethylethanethioamide 2-(2-butyl-4-methyl-1-((2'-(2-methyl-2H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)methyl)-6-oxo-1,6-dihydropyrimidi;2-(2-butyl-4-methyl-1-((2'-(1-methyl- 1H-tetrazol-5-yl)-[1,1'-biphenyl]-4- yl)methyl)-6-oxo-1,6- dihydropyrimidin-5-yl)-N,Ndimethylethanethioamide 2-(2-butyl-4-methyl-1-((2'-(2-methyl- 2H-tetrazol-5-yl)-[1,1'-biphenyl]-4- yl)methyl)-6-oxo-1,6- dihydropyri
CBNumber:
CB33335128
Summenformel:
Molgewicht:
0
MOL-Datei:
Mol file

2-(2-butyl-4-methyl-1-((2'-(1-methyl- 1H-tetrazol-5-yl)-[1,1'-biphenyl]-4- yl)methyl)-6-oxo-1,6- dihydropyrimidin-5-yl)-N,Ndimethylethanethioamide 2-(2-butyl-4-methyl-1-((2'-(2-methyl- 2H-tetrazol-5-yl)-[1,1'-biphenyl]-4- yl)methyl)-6-oxo-1,6- dihydropyri Eigenschaften

Sicherheit

2-(2-butyl-4-methyl-1-((2'-(1-methyl- 1H-tetrazol-5-yl)-[1,1'-biphenyl]-4- yl)methyl)-6-oxo-1,6- dihydropyrimidin-5-yl)-N,Ndimethylethanethioamide 2-(2-butyl-4-methyl-1-((2'-(2-methyl- 2H-tetrazol-5-yl)-[1,1'-biphenyl]-4- yl)methyl)-6-oxo-1,6- dihydropyri Chemische Eigenschaften,Einsatz,Produktion Methoden

2-(2-butyl-4-methyl-1-((2'-(1-methyl- 1H-tetrazol-5-yl)-[1,1'-biphenyl]-4- yl)methyl)-6-oxo-1,6- dihydropyrimidin-5-yl)-N,Ndimethylethanethioamide 2-(2-butyl-4-methyl-1-((2'-(2-methyl- 2H-tetrazol-5-yl)-[1,1'-biphenyl]-4- yl)methyl)-6-oxo-1,6- dihydropyri Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte


2-(2-butyl-4-methyl-1-((2'-(1-methyl- 1H-tetrazol-5-yl)-[1,1'-biphenyl]-4- yl)methyl)-6-oxo-1,6- dihydropyrimidin-5-yl)-N,Ndimethylethanethioamide 2-(2-butyl-4-methyl-1-((2'-(2-methyl- 2H-tetrazol-5-yl)-[1,1'-biphenyl]-4- yl)methyl)-6-oxo-1,6- dihydropyri Anbieter Lieferant Produzent Hersteller Vertrieb Händler.

Global( 7)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
Beijing Comparison Pharmaceutical Technology Co., Ltd 010-010-52878169 15801002657
sales@bjcomparison.com China 4937 58
Wuxi Zhongkun Biochemical Technology Co., Ltd. 0510-85629785 18013409632
sales@reading-chemicals.com China 15178 58
XinYao(Shenzhen) Biological Technology Co., Ltd. 0755-89880280
3004662104@qq.com China 1829 58
Wuxi Helen Biotechnology Co., Ltd., 0510-85629785 18013409632
sales@reading-chemicals.com China 14081 58
SHENZHEN PHYSTANDARD BIO-TECH CO.,LTD 0755-0755-0755-83725350 13380397412
3001280422@qq.com China 10003 58
Shanghai Botuo Biotechnology Co., LTD 16621358918
botuopharma888@163.com China 9208 58
Hubei Moco Chemical Co., Ltd. 18576690171
3001071511@qq.com China 11100 58

  • 2-(2-butyl-4-methyl-1-((2'-(1-methyl- 1H-tetrazol-5-yl)-[1,1'-biphenyl]-4- yl)methyl)-6-oxo-1,6- dihydropyrimidin-5-yl)-N,Ndimethylethanethioamide 2-(2-butyl-4-methyl-1-((2'-(2-methyl- 2H-tetrazol-5-yl)-[1,1'-biphenyl]-4- yl)methyl)-6-oxo-1,6- dihydropyri
  • Fimasartan Impurity I
  • 2-(2-butyl-4-methyl-1-((2'-(1-methyl-1H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)methyl)-6-oxo-1,6-dihydropyrimidin-5-yl)-N,N-dimethylethanethioamide compound with 2-(2-butyl-4-methyl-1-((2'-(2-methyl-2H-tetrazol-5-yl)-[1,1'-biphenyl]-4-y
  • 2-(2-butyl-4-methyl-1-((2'-(1-methyl-1H-tetrazol-5-yl)-[1,1'- biphenyl]-4-yl)methyl)-6-oxo-1,6-dihydropyrimidin-5-yl)-N,N- dimethylethanethioamide compound 2-(2-butyl-4-methyl-1 -((2'-(2-methyl-2H-t
  • 2-(2-butyl-4-methyl-1-((2'-(1-methyl-1H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)methyl)-6-oxo-1,6-dihydropyrimidin-5-yl)-N,N-dimethylethanethioamide 2-(2-butyl-4-methyl-1-((2'-(2-methyl-2H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)methyl)-6-oxo-1,6-dihydropyrimidi
Copyright 2019 © ChemicalBook. All rights reserved